But that could change soon: This July, the Pharmacy Compounding Advisory Committee (PCAC) will discuss whether peptides such as BPC-157, TB-500, MOTS-c, and Semax (among others) should be included on the FDAs 503A Bulks List
But in 2023, the Food and Drug Administration rightly moved peptides to a no-compounding-allowed status called Category 2 due to concerns about safety and lack of clinical trial data
Store reconstituted solutions below 4C (39F) Do not freeze-thaw the peptide repeatedly (temperature fluctuations may affect peptide integrity) Note: Under appropriate laboratory conditions, reconstituted Glow 70 Peptide solutions may remain suitable for use for up to 30 days
At Blue Skies Health & Wellness, patients choose us because we care for the whole person: Patients often notice: At Blue Skies, our mission is to help you feel strong, clear-minded, and ready to enjoy every day